Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucentis with or without Visudyne PDT in AMD
NCT00429962Phase 3Completed
- Sponsor
- University Hospital Basel
- Start
- Jul 2006
- Primary completion
- Jun 2008
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of verteporfin in age-related macular degeneration (AMD), choroidal neovascularization (CNV), sponsored by University Hospital Basel. Started Jul 2006; status: completed.
02
Drugs
verteporfin
03
Conditions
age-related macular degeneration (AMD)choroidal neovascularization (CNV)
Beyond the preview
Go deeper on NCT00429962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429962.